AWA
GILD icon

AGH Wealth Advisors’s Gilead Sciences GILD Stock Holding History

AGH Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
2,061
+50
+2% +$7K 0.21% 92
2025
Q4 		$247K Sell
2,011
-140
-7% -$17K 0.19% 99
2025
Q3 		$239K Sell
2,151
-78
-3% -$8.87K 0.18% 106
2025
Q2 		$247K Buy
2,229
+370
+20% +$39.4K 0.2% 100
2025
Q1 		$208K Buy
+1,859
New +$192K 0.2% 110

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AGH Wealth Advisors's GILD Position: Q1 2026 in Review

AGH Wealth Advisors increased its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, buying an estimated $7K and bringing the position to 2,061 shares worth $287K. The position accounts for 0.21% of the portfolio, ranked #92.

AGH Wealth Advisors first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AGH Wealth Advisors held 2,061 shares of Gilead Sciences worth $287K as of Q1 2026.
  • AGH Wealth Advisors bought 50 Gilead Sciences shares in Q1 2026, an estimated $7K.
  • Gilead Sciences made up 0.21% of AGH Wealth Advisors's portfolio in Q1 2026, its #92 holding.
  • AGH Wealth Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AGH Wealth Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.